Advanced Biomed Inc. Common Stock (ADVB) Earnings History
Net Loss5 years of earnings data (2021–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Advanced Biomed Inc. Common Stock (ADVB) Earnings Overview
As of June 29, 2026, Advanced Biomed Inc. Common Stock (ADVB) reported trailing twelve-month net income of -$204,124, reflecting -23.1% year-over-year growth. The company earned $-0.16 per diluted share over the past four quarters.
Looking at the long-term picture, ADVB's historical earnings data spans multiple years. The company achieved its highest annual net income of -$101,524 in fiscal 2025, representing a new all-time high.
Advanced Biomed Inc. Common Stock is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including AGEN ($65M net income, 0.1% margin), IMVT (-$506M net income), KROS (-$85M net income, 35.7% margin), ADVB has comparable earnings metrics. Compare ADVB vs AGEN →
ADVB Earnings vs Peers
Earnings metrics vs comparable public companies
ADVB Historical Earnings Data (2021–2025)
5 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $-101,524 | +96.4% | $-94,112 | $-0.16 | - | - |
| 2024 | -$3M | +25.5% | -$3M | $-0.13 | - | - |
| 2023 | -$4M | +7.3% | -$3M | $-0.11 | - | - |
| 2022 | -$4M | -119.2% | -$2M | $-0.03 | - | - |
| 2021 | -$2M | - | -$2M | $-0.08 | - | - |
Download Data
Export ADVB earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
5+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
ADVB — Frequently Asked Questions
Quick answers to the most common questions about buying ADVB stock.
What is ADVB earnings per share (EPS)?
ADVB trailing twelve-month (TTM) diluted EPS is $-0.16, reflecting -23.1% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2021 to 2025 is available in the table on this page.
What is Advanced Biomed Inc. Common Stock's net income?
Advanced Biomed Inc. Common Stock (ADVB) trailing twelve-month net income is $-204124.00 as of 2025. Earnings declined -23.1% year-over-year.
Is ADVB profitable?
ADVB is not currently profitable on a TTM basis, reporting a net loss of $-204124.00. Net margin is N/A. Investors should monitor for a return to profitability.
What is ADVB's earnings growth rate?
ADVB compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2021 to 2025.
What are ADVB's profit margins?
Advanced Biomed Inc. Common Stock net profit margin is N/A, operating margin is N/A, and gross margin is N/A. Below-average margins reflect competitive or cost pressures. Return on Equity is -0.0%.
Is ADVB growing earnings?
ADVB earnings are declining — EPS fell -23.1% year-over-year. TTM net income dropped to $-204124.00. This contrasts with the 5-year CAGR of N/A.
What was ADVB's best earnings year?
Advanced Biomed Inc. Common Stock's highest annual net income on record is $-101524.00, achieved in fiscal year 2025. Earnings history on this page spans 2021 to 2025 and includes all annual and quarterly figures.
What were ADVB's earnings last quarter?
ADVB's most recent reported quarter was Q3 2026. Net income was $-15455.00 with diluted EPS of $-0.01. For a full breakdown of all quarters, see the quarterly earnings table on this page.